<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24">
 <label>24.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ang</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>O'Reilly</surname>
    <given-names>EM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Carvajal</surname>
    <given-names>RD</given-names>
   </name>, 
   <name name-style="western">
    <surname>Capanu</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gonen</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Doyle</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ghossein</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Schwartz</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Jacobs</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ma</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Schwartz</surname>
    <given-names>GK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Abou-Alfa</surname>
    <given-names>GK</given-names>
   </name>
  </person-group>
  <year>2012</year>
  <article-title>A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma</article-title>. 
  <source>Gastrointest Cancer Res</source>
  <volume>5</volume>:
  <fpage>185</fpage>â€“
  <lpage>189</lpage>.
  <pub-id pub-id-type="pmid">23293699</pub-id>
 </mixed-citation>
</ref>
